Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in the marrow …

Oct 25, 2024 · Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly formed or don't work properly. Myelodysplastic syndromes result from something amiss in the …

If you have myelodysplastic syndrome (MDS), you have a form of cancer that’s a chronic illness. No illness is easy, but having a chronic illness means also managing the emotional impact of an illness …

Apr 7, 2025 · Myelodysplastic syndromes (MDS) are a rare group of diseases in which your body's bone marrow doesn’t make enough healthy blood cells. Instead, it makes too many early forms of blood …

Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant. Learn more about newly diagnosed or recurrent …

Myelodysplastic syndromes (MDS) are an often unrecognized, under-diagnosed, rare group of bone marrow failure disorders, where the body no longer makes enough healthy, normal blood cells in the …

Myelodysplastic syndromes (MDS) are a group of cancers that affect blood and bone marrow, with varying degrees of severity, treatments, and life expectancy.

Myelodysplastic syndromes (MDSs) are a group of closely related disorders that arise in the bone marrow. Learn more about MDS diagnosis and treatment at Memorial Sloan Kettering.

Physicians and scientists from Fred Hutch and UW Medicine are testing new treatments for myelodysplastic syndrome (MDS) subtypes and finding new ways to use current treatments.

Minimum Data Set (MDS) is a federal system used by Medicare-certified facilities to submit patient outcomes. We provide technical assistance and training for using this system.